avodart

DRUG3 trials

Sponsors

GlaxoSmithKline, Bay State Clinical Trials, Inc., Dongkook Pharmaceutical Co., Ltd.

Conditions

Benign Prostate HyperplasiaHealthyNeoplasms, ProstateProstate CancerProstate Cancer After a Radical Treatment

Phase 1

Safety and Pharmacokinetic Characteristics of DKF-313

CompletedNCT02352311

Dongkook Pharmaceutical Co., Ltd.Benign Prostate Hyperplasia, Healthy

Start: 2015-01-31End: 2015-06-30Updated: 2021-07-06

Phase 2

ARTS - AVODART After Radical Therapy For Prostate Cancer Study

CompletedNCT00558363

GlaxoSmithKlineNeoplasms, Prostate, Prostate Cancer After a Radical Treatment

Start: 2007-11-30End: 2011-03-31Updated: 2012-03-21

Phase 4

Study Assessing The Efficacy And Safety Of Avodart (Dutasteride) At Improving Urinary Symptoms In Men With Prostate Cancer Who Are Undergoing Seed Implantation

CompletedNCT00805701

Bay State Clinical Trials, Inc.Prostate Cancer

Start: 2009-01-31End: 2014-04-30Updated: 2014-05-14

Related Papers

Dutasteride treatment over 2 years delays prostate-specific antigen progression in patients with biochemical failure after radical therapy for prostate cancer: results from the randomised, placebo-controlled Avodart After Radical Therapy for Prostate Cancer Study (ARTS).

2012-11-1235 citations